Literature DB >> 15454185

A microassay for measurement of Fc function of human immunoglobulin preparations by using tetanus toxoid as antigen.

Anto Vrdoljak1, Anda Trescec, Bojan Benko, Mirjana Simic.   

Abstract

In order to minimize possible adverse reactions, the functional integrity of proteins in products derived from human plasma has to be unaffected by methods of preparation and storage conditions. Numerous biologically relevant functions of IgG, a major component of immunoglobulin for intravenous use preparations (IVIG), rely on the integrity of Fc fragments. Manufacturers are obliged to prove that Fc-mediated functions are maintained in IVIG preparations. The European Pharmacopoeia's monograph proposes a Rubella antigen-based test for Fc function of immunoglobulins. We present a modification of the proposed method achieved by using more convenient and readily available tetanus toxoid as an alternative antigen target and by adapting the procedure for the use on microtitre plates, thus greatly enhancing its feasibility and sample throughput. The test conditions were optimized so that batch-to-batch variability in tetanus antibody content did not influence the result. The precision of the test was within +/- 5%. By using this test, we compared Fc functionality of 9 commercial IVIG-7S preparations, which were prepared by using different virus inactivation/removal approaches. No significant differences between them have been found.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454185     DOI: 10.1016/j.biologicals.2004.03.001

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  1 in total

1.  Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.

Authors:  Sebastian Kobold; Tim Luetkens; Britta Marlen Bartels; Yanran Cao; York Hildebrandt; Orhan Sezer; Henrike Reinhard; Julia Templin; Katrin Bartels; Nesrine Lajmi; Friedrich Haag; Carsten Bokemeyer; Nicolaus Kröger; Djordje Atanackovic
Journal:  Clin Dev Immunol       Date:  2012-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.